Sentences with phrase «in dialysis patients»

In dialysis patients, concentrations of greater than 80 micrograms per liter plasma aluminum, have been associated with encephalopathy (any brain disease that alters brain function or structure).
The researchers» analysis included 22 pregnancies in the Toronto Pregnancy and Kidney Disease Clinic and Registry (2000 - 2013) with 70 pregnancies in the American Registry for Pregnancy in Dialysis Patients (1990 - 2011).
«Also whether sickle trait is more common in dialysis patients because it contributes to kidney disease should be explored further in future research.»
The technique also has specific relevance to understanding sodium and water balance in dialysis patients.
Better ways of preventing foot problems in dialysis patients with diabetes could reduce the 100 or so associated amputations that take place every week in the UK, according to Diabetes UK - funded research being presented this week at the European Association for the Study of Diabetes (EASD) in Lisbon.

Not exact matches

The worst performer in Buffett's portfolio was DaVita (dva), the health care dialysis company that treats patients with diabetes and whose stock has been punished by uncertainty over the Affordable Care Act, better known as Obamacare.
Since massive Hurricane Maria struck in September and knocked out the dialysis center on the tiny satellite island of Vieques, more than a dozen patients needing treatment now must fly several times a week to the main island.
DaVita teammates far and wide showed up to help support any dialysis patient that could make it in for lifesaving treatment, including dozens of patients from neighboring clinics.
Because Dr. Giullian, the local team and volunteers found a way to provide care during the natural disaster, they were able to treat every patient that required dialysis in the facility.
The dialysis unit at the Lutheran World Federation's Augusta Victoria Hospital in Jerusalem was treating 20 patients a day, nearly double its normal load.
The GMB union agreed that renal dialysis and oncology patients will be responded to when they call for help in the north - west.
Caribbean Life article on Borough President Adams commemorating Diabetes Awareness Day at Rogosin Institute — Brooklyn East in East New York, donating crocheted blankets, scarves, and socks to dialysis patients across the borough.
The patient, who had been admitted to the hospital on September 28 after contracting the virus in Liberia, had been placed on a ventilator and was receiving dialysis in the final days before his death.
Fewer deaths were reported among dialysis and kidney transplant patients in 2013, dropping by 28 percent and 40 percent, respectively, since 1996.
Patients with diabetes and suffering from acute kidney injury (AKI), proteinuria and uncontrolled blood sugar experience a sharp reduction in the number of years they have healthy renal function before being forced onto dialysis, according to researchers at the University of Cincinnati (UC) College of Medicine.
«Blood pressure medications reduce stroke, heart attack in peritoneal dialysis patients: New study finds a 16 percent reduction in cardiovascular events with the use of ACEIs and ARBs.»
«The majority of patients with chronic kidney disease, particularly those in the more advanced stages who require dialysis, exhibited some degree of loss of their sense of smell, which correlated with reduced nutritional status,» says Teodor Paunescu, PhD, of the MGH Division of Nephrology, corresponding author of the study.
In patients with chronic kidney disease who are not on dialysis, ACEIs and ARBs slow the progression of diabetic nephropathy and reduce cardiovascular risk.
For this reason, Avrum Gillespie, MD (Temple University School of Medicine) and his colleagues looked for disparities in dialysis clinics and included patients both potentially eligible and ineligible for receiving a transplant.
In the current study, McAllister's team implanted them into 10 kidney dialysis patients in Argentina and Poland, all of whom had suffered previous graft failureIn the current study, McAllister's team implanted them into 10 kidney dialysis patients in Argentina and Poland, all of whom had suffered previous graft failurein Argentina and Poland, all of whom had suffered previous graft failures.
For the purpose of this replacement therapy, the patient's blood is purified using filters, in a process similar to dialysis, and then it is reinjected into the patient via an infusion drip; alternatively, it is replaced with a blood substitute such as albumin.
Previous studies of their effectiveness in patients with end - stage renal disease produced mixed results, leading researchers to conduct the review of records of all U.S. patients who had initiated peritoneal dialysis from 2007 to 2011.
Scientists report today that artificial blood vessels made using a person's own skin cells work well in patients receiving kidney dialysis.
Two classes of blood pressure medications, angiotensin - converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), are associated with a 16 % lower risk of strokes, heart attacks and death in patients with end - stage renal disease who are undergoing peritoneal dialysis, a new study in the journal, Nephrology Dialysis Transplantation, dialysis, a new study in the journal, Nephrology Dialysis Transplantation, Dialysis Transplantation, reports.
In the early 1980s, a team in France found that dialysis patients with advanced kidney disease had fewer cardiovascular complications and longer survival times if they were overweighIn the early 1980s, a team in France found that dialysis patients with advanced kidney disease had fewer cardiovascular complications and longer survival times if they were overweighin France found that dialysis patients with advanced kidney disease had fewer cardiovascular complications and longer survival times if they were overweight.
«Many dialysis patients are unprepared for natural disasters: Study finds patients» disaster preparedness lacking in the wake of Hurricane Sandy.»
In 2015, 87,538 patients with end - stage renal disease died while on dialysis (16.3 percent of all dialysis patients are awaiting kidney transplants), and 18,805 kidney transplantations were performed that same year.
The findings suggest that the presence of sickle cell trait may explain, at least in part, prior observations of greater doses of anemia medications administered to African - American dialysis patients relative to Caucasian patients.
The investigators also found that sickle cell trait was slightly more common among dialysis patients, present in 10 % of study participants compared with 6.5 % to 8.7 % in the general African - American population.
The answers, I learned, lay in the grinding poverty and entrenched corruption of India, the desperation of patients on dialysis, and the transnational nature of the black market transplant business — which, though dominated by the kidney exchange, includes livers and hearts as well.
In a few years, dialysis machines with mini livers inside could be used to clean the blood of patients who have been poisoned or are waiting for a transplant.
Michelle Hladunewich, MD (Sunnybrook Health Sciences Centre, in Toronto) and her colleagues assessed the effects of such intensive dialysis on pregnancy outcomes by comparing patients from Toronto with that from the United States.
Based on this review, they suggest a «probable» association between vitamin D levels and birth weight, dental caries in children, maternal vitamin D levels at term and parathyroid hormone levels in chronic kidney disease patients requiring dialysis, but «further studies and better designed trials are needed to draw further conclusions.»
In human trials, researchers remove some of patients» T cells through a process similar to dialysis and then engineer them in a laboratory to add the gene for the CAR so that the new receptor is expressed in the T cellIn human trials, researchers remove some of patients» T cells through a process similar to dialysis and then engineer them in a laboratory to add the gene for the CAR so that the new receptor is expressed in the T cellin a laboratory to add the gene for the CAR so that the new receptor is expressed in the T cellin the T cells.
«Some potential impacts of reaching this goal are that patients might opt more for home dialysis options, and more patients may be able to start their preferred option in a non-urgent manner and not require admission to hospital to start dialysis
Researchers in Taiwan examined the association between ACEI / ARB use and the risk of long - term dialysis and death in a nationwide group of 28,497 patients in a study by Ta - Wei Hsu, M.D., of the National Yang - Ming University Hospital, and colleagues.
But most large clinical trials of ACEI / ARB exclude patients with the most advanced stage of CKD predialysis, perhaps out of concern that the drugs can cause renal failure and the need for dialysis, so it remains unclear whether that therapy is effective in patients with advanced CKD, according to the study background.
While the alert system did not improve outcomes, in a subset of patients it did increase interventions, including more renal consultations and dialysis.
«This in effect means it may delay the need for a kidney transplant or dialysis in patients with this disease.»
The one - year survival rate for patients on dialysis was 50 percent in 1995 and 95 percent in 2013; survival for patients on a ventilator was 49 percent in 1994 and 94 percent in 2013.
Between 10 and 30 per cent of dialysis patients in France carry the hepatitis C virus compared to 1 per cent of the general population.
The research also indicates that a low protein, low salt diet may not only slows the progression of CKD as an effective adjunct therapy, but it can also be used for the management of uremia, or high levels of urea and other uremic toxins in the blood, in late - stage or advanced CKD and help patients defer the need to initiate dialysis.
In severe cases, patients must undergo dialysis or a kidney transplantation to survive.
Research has shown that kidney transplantation results in longer survival, better quality of life, and long - term cost savings compared with dialysis for patient with kidney failure.
One man, designated Patient C, infected seven others, six of whom had undergone dialysis at the same time he did, the team reports June 19 in the New England Journal of Medicine.
Additionally, a kidney transplant saves a patient about $ 250,000 in dialysis treatments that would otherwise be necessary.
ARANESP ® is used to treat anemia, a deficiency in the number of red blood cells, caused by chronic kidney failure in patients both on dialysis and not on dialysis.
Patients must have adequate coagulation (international normalized ratio (INR) or prothrombin time (PT), partial thromboplastin time (PTT) ≤ 1.5 times ULN) • Adequate liver function (total bilirubin ≤ 1.5 times the ULN, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 times ULN Exclusion Criteria: • Presence of active / uncontrolled central nervous system involvement • History of clinically significant cardiac disease; uncontrolled hypertension • Left ventricular ejection fraction (LVEF) < 45 % • Allogeneic stem cell transplant within 100 days before first dose of study drug • Known history of human immunodeficiency virus (HIV) infection • Chronic or active hepatitis B or C, requiring antiviral therapy • Evidence of history of bleeding disorder, dialysis, or coexisting cancer that is distinct in primary site or histology from the cancer evaluated in this study • Serious, uncontrolled infection • Unresolved chronic toxicity > grade 1 from prior therapy • Use of strong CYP3A4 inhibitors or strong inducers within 7 days prior to the start of study treatment and for the duration of the study
Researchers at Whitehead Institute have identified a key target protein of glucocorticoids, the drugs that are used to increase red blood cell production in patients with certain types of anemia, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy.
In a feasibility trial in Argentina, Cytograft implanted its engineered vessels into two dialysis patientIn a feasibility trial in Argentina, Cytograft implanted its engineered vessels into two dialysis patientin Argentina, Cytograft implanted its engineered vessels into two dialysis patients.
a b c d e f g h i j k l m n o p q r s t u v w x y z